Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Therapies02:49

Cancer Therapies

7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

404
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
404

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-time sensing-integrated organoid-on-a-chip platforms: Technological progress and emerging biomedical applications.

Bioactive materials·2026
Same author

A hypoxic microfluidic organoid-on-a-chip system for studying the efficacy of metronidazole-modified nanomaterials against cholangiocarcinoma established within the chip.

Lab on a chip·2026
Same author

Advances in ultrasensitive detection technologies for blood-based biomarkers of Alzheimer's disease.

Journal of materials chemistry. B·2026
Same author

ProtoDiff: Prototypical Diffusion Model for Few-Shot Molecular Image Generation.

IEEE transactions on computational biology and bioinformatics·2025
Same author

A prognostic framework integrating endoplasmic reticulum stress dynamics reveals clinical stratification and differential prognostic attributes in osteosarcoma patients.

Frontiers in medicine·2025
Same author

Determining the optimal transplantation window in hepatic organoids via real-time biosensing of vascularization and metabolic maturation utilizing the integrated organoid-on-a-chip platform.

Biosensors & bioelectronics·2025

Related Experiment Video

Updated: May 13, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.0K

Radiation-Activated Cobalt-Based Zeolite Imidazolate Frameworks for Tumor Multitherapy.

Qijun Du1,2, Hongwei Jiang3, Di Wu1,2,4

  • 1Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610065, China.

Biomaterials Research
|April 16, 2025
PubMed
Summary

This study introduces novel nanoparticles that enhance radiation dynamic therapy (RDT) by overcoming tumor hypoxia and increasing cancer cell death. The new drug delivery system shows promise for improved radiation-based cancer treatments with minimal toxicity.

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.0K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.4K

Related Experiment Videos

Last Updated: May 13, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.0K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.0K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.4K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Radiation dynamic therapy (RDT) shows promise for cancer treatment but faces challenges like poor radiation sensitization and tumor hypoxia.
  • Developing effective strategies to overcome these limitations is crucial for enhancing RDT efficacy.

Purpose of the Study:

  • To develop a novel biodegradable drug delivery system for collaborative RDT and radiotherapy (RT).
  • To investigate the potential of quercetin and sorafenib-loaded ZIF67 nanoparticles (QSZP NPs) coated with polydopamine in overcoming tumor hypoxia and enhancing RDT.

Main Methods:

  • Synthesized polydopamine-coated ZIF67 nanoparticles loaded with quercetin and sorafenib (QSZP NPs).
  • Evaluated QSZP NPs for x-ray sensitization and reactive oxygen species (ROS) generation in vitro.
  • Assessed the therapeutic efficacy and systemic toxicity of QSZP NPs in a HepG2 tumor-bearing mouse model under X-ray irradiation.

Main Results:

  • QSZP NPs effectively controlled the tumor microenvironment (TME) and overcame hypoxia.
  • In vitro studies confirmed the nanoparticles' potential for x-ray sensitization and ROS-mediated effects.
  • In vivo studies demonstrated good therapeutic effects with no apparent systemic toxicity in a HepG2 tumor model.

Conclusions:

  • The developed QSZP NPs offer a promising approach for synergistic RDT/RT and anti-angiogenic cancer therapy.
  • This novel nanoparticle system effectively addresses tumor hypoxia and enhances radiation-based cancer treatment outcomes.